RELATIONSHIP BETWEEN INITIAL PROSTATE SPECIFIC ANTIGEN LEVEL AND SUBSEQUENT PROSTATE CANCER DETECTION IN A LONGITUDINAL SCREENING STUDY
- 1 July 2004
- journal article
- Published by Wolters Kluwer Health in Journal of Urology
- Vol. 172 (1) , 90-93
- https://doi.org/10.1097/01.ju.0000132133.10470.bb
Abstract
Previous studies of archived blood samples from nonscreened populations have shown an association between the prostate specific antigen (PSA) and the subsequent detection of prostate cancer. In the current study we evaluated the relationship between the initial screening PSA and the subsequent risk of prostate cancer detected in a prospective, longitudinal screening study. We also examined the relationship between initial PSA and the clinicopathological features of the cancers detected. Between May 1991 and November 2001 we enrolled 26,111 volunteers in our PSA and digital rectal examination based prostate cancer screening study. The men were followed biannually or annually depending on the results of previous screening tests. The chi-square and Kruskal-Wallis tests were used to compare the clinical stage, pathological stage and Gleason score of subsequently detected prostate cancers as well as the time to cancer detection in different initial screening PSA strata. The initial screening PSA stratum was strongly associated with the subsequent detection of prostate cancer as well as the clinicopathological stage and grade of the cancers detected. Even in the lower PSA ranges initial screening serum PSA can help identify men at increased risk for subsequent prostate cancer detected in a longitudinal screening study.Keywords
This publication has 18 references indexed in Scilit:
- Prostate-specific antigen cutoff of 2.6 ng/mL for prostate cancer screening is associated with favorable pathologic tumor featuresUrology, 2002
- Overdiagnosis Due to Prostate-Specific Antigen Screening: Lessons From U.S. Prostate Cancer Incidence TrendsJNCI Journal of the National Cancer Institute, 2002
- American Cancer Society Guidelines for the Early Detection of CancerCA: A Cancer Journal for Clinicians, 2002
- VALIDITY OF THE PROSTATE SPECIFIC ANTIGEN TEST FOR PROSTATE CANCER SCREENING: FOLLOWUP STUDY WITH A BANK OF 21,000 SERA IN FINLANDJournal of Urology, 2001
- Low levels of prostate-specific antigen predict long-term risk of prostate cancer: results from the Baltimore Longitudinal Study of AgingUrology, 2001
- Inflammation in Prostate Biopsies of Men without Prostatic Malignancy or Clinical ProstatitisEuropean Urology, 2000
- Proliferative Inflammatory Atrophy of the ProstateThe American Journal of Pathology, 1999
- Prostate cancer detection in men with serum PSA concentrations of 2.6 to 4.0 ng/mL and benign prostate examination. Enhancement of specificity with free PSA measurementsJAMA, 1997
- A prospective evaluation of plasma prostate-specific antigen for detection of prostatic cancerPublished by American Medical Association (AMA) ,1995
- Measurement of Prostate-Specific Antigen in Serum as a Screening Test for Prostate CancerNew England Journal of Medicine, 1991